SC
REGN icon

Savant Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Savant Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
3,687
+1,746
+90% +$1.19M 0.01% 548
2026
Q1 		$1.5M Sell
1,941
-113
-6% -$86.5K 0.01% 490
2025
Q4 		$1.59M Buy
2,054
+566
+38% +$384K 0.01% 455
2025
Q3 		$837K Buy
1,488
+629
+73% +$356K 0.01% 630
2025
Q2 		$451K Sell
859
-31
-3% -$17.3K ﹤0.01% 780
2025
Q1 		$565K Sell
890
-95
-10% -$65.3K ﹤0.01% 644
2024
Q4 		$701K Buy
985
+172
+21% +$144K 0.01% 779
2024
Q3 		$855K Buy
813
+189
+30% +$210K 0.01% 699
2024
Q2 		$656K Buy
624
+75
+14% +$72.7K 0.01% 708
2024
Q1 		$528K Buy
549
+35
+7% +$33.3K 0.01% 711
2023
Q4 		$451K Buy
514
+117
+29% +$96.3K 0.01% 589
2023
Q3 		$327K Buy
397
+26
+7% +$20.4K ﹤0.01% 632
2023
Q2 		$267K Buy
371
+5
+1% +$3.85K ﹤0.01% 677
2023
Q1 		$301K Buy
+366
New +$276K 0.01% 594
2022
Q4 		– Sell
-322
Closed -$222K – 615
2022
Q3 		$222K Buy
+322
New +$203K 0.01% 492
2022
Q2 		– Sell
-324
Closed -$226K – 586
2022
Q1 		$226K Buy
+324
New +$205K 0.01% 519
2020
Q3 		– Sell
-360
Closed -$225K – 416
2020
Q2 		$225K Buy
+360
New +$204K 0.02% 362
2017
Q3 		– Sell
-480
Closed -$236K – 276
2017
Q2 		$236K Buy
+480
New +$210K 0.06% 239

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Savant Capital's REGN Position: Q2 2026 in Review

Savant Capital increased its Regeneron Pharmaceuticals (REGN) stake by 90% in Q2 2026, buying an estimated $1.19M and bringing the position to 3,687 shares worth $2.59M. The position accounts for 0.01% of the portfolio, ranked #548.

Savant Capital first reported a position in REGN in Q2 2017 and has held it in 18 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Savant Capital held 3,687 shares of Regeneron Pharmaceuticals worth $2.59M as of Q2 2026.
  • Savant Capital bought 1,746 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.19M.
  • Regeneron Pharmaceuticals made up 0.01% of Savant Capital's portfolio in Q2 2026, its #548 holding.
  • Savant Capital first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 18 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.